Company insider dossier

Tilray Inc insider intelligence

TLRY filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Drug Manufacturers - Specialty & Generic Data API
46/100

Balanced insider tape

89/100 confidence
Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Latest evidence
6 Aug 2026

Investment committee read

Balanced insider tape

Acquisition and disposal evidence is mixed after low-information compensation and derivative activity is separated out.

Wait for clearer clustering

Evidence in favour

  • 3 distinct acquisition events survive duplicate and security-type controls.
  • Participation spans 10 named insiders rather than one filing source.
  • The latest qualifying evidence is fresh, dated 06 Aug 2026.

Decision risks

  • Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Conviction46Balanced insider tape
Confidence89Deep evidence
Named insiders10participating in the tape
Controlled events13directional common-share events
Acquisition value$69.2Knormalized amount
Disposal value$2.3Mnormalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

17.2013.8010.407.003.60 Acquisition · 6 Aug 2026 · $11.1KAcquisition · 4 Aug 2026 · $46.2KAcquisition · 3 Aug 2026 · $11.9KAcquisition · 30 Jul 2026 · Not reportedAcquisition · 30 Jul 2026 · Not reportedAcquisition · 30 Jul 2026 · Not reportedAcquisition · 30 Jul 2026 · Not reportedDisposal · 30 Jul 2026 · $261.9KDisposal · 30 Jul 2026 · $58.1KDisposal · 30 Jul 2026 · $54.3KDisposal · 30 Jul 2026 · $38.5KAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedAcquisition · 29 Jul 2026 · Not reportedDisposal · 29 Jul 2026 · $906.0KDisposal · 29 Jul 2026 · $198.1KDisposal · 29 Jul 2026 · $184.9KDisposal · 29 Jul 2026 · $120.5KDisposal · 29 Jul 2026 · $86.0KDisposal · 29 Jul 2026 · $86.0KDisposal · 29 Jul 2026 · $86.0KDisposal · 21 Apr 2026 · $232.9K
Feb 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
4.57 USD
One-week move
+0.7%
Four-week move
+3.4%
Fair-value gap
-64.7%
Trend signal
Inactive
Relative strength
-54.1

Directional balance

Controlled event mix

23.1%acquisition
Acquisition events
3
Disposal events
10
Net value
-$2.2M

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

025 May
001 Jun
008 Jun
015 Jun
022 Jun
029 Jun
006 Jul
013 Jul
020 Jul
4927 Jul
303 Aug
010 Aug

Named participants

Insider conviction by person

MERTON, CARL AChief Financial Officer563 events
FALTISCHEK, DENISE MChief Strategy Officer543 events
GENDEL, MITCHELLGlobal General Counsel543 events
COHEN, STEVEN MICHAELDirector500 events
LOONEY, THOMAS P.Director500 events
CLANACHAN, DAVID FDirector281 events
HERHALT, JOHANN MICHAELDirector281 events
HOPKINSON, DAVID G.Director281 events
PERSOFSKY, RENAHDirector281 events
SIMON, IRWIN DDirector, President and CEO252 events

Evidence quality

Security and transaction context

Common equity29
Equity compensation24
Options and derivatives0
Other securities0

Role architecture

Who is participating

Director22
Other executive16
Finance leadership8
CEO and chair7

Transaction evidence

Auditable TLRY filing ledger

Showing 31 to 53 of 53.

HERHALT, JOHANN MICHAELDirector
DisposalEquity compensation
43104 sharesRestricted Stock Units
Not reportedContext evidence
HERHALT, JOHANN MICHAELDirector
AcquisitionCommon equity
43104 sharesCommon Stock
Not reportedContext evidence
HOPKINSON, DAVID G.Director
DisposalEquity compensation
43104 sharesRestricted Stock Units
Not reportedContext evidence
HOPKINSON, DAVID G.Director
AcquisitionCommon equity
43104 sharesCommon Stock
Not reportedContext evidence
LOONEY, THOMAS P.Director
AcquisitionCommon equity
43104 sharesCommon Stock
Not reportedContext evidence
LOONEY, THOMAS P.Director
DisposalEquity compensation
43104 sharesRestricted Stock Units
Not reportedContext evidence
MERTON, CARL AChief Financial Officer
AcquisitionEquity compensation
180302 sharesRestricted Stock Units
Not reportedContext evidence
MERTON, CARL AChief Financial Officer
AcquisitionCommon equity
60417 sharesCommon Stock
Not reportedContext evidence
MERTON, CARL AChief Financial Officer
DisposalEquity compensation
60417 sharesRestricted Stock Units
Not reportedContext evidence
PERSOFSKY, RENAHDirector
AcquisitionEquity compensation
62657 sharesRestricted Stock Units
Not reportedContext evidence
PERSOFSKY, RENAHDirector
DisposalEquity compensation
43104 sharesRestricted Stock Units
Not reportedContext evidence
PERSOFSKY, RENAHDirector
AcquisitionCommon equity
43104 sharesCommon Stock
Not reportedContext evidence
SIMON, IRWIN DDirector, President and CEO
AcquisitionEquity compensation
1289211 sharesRestricted Stock Units
Not reportedContext evidence
SIMON, IRWIN DDirector, President and CEO
DisposalEquity compensation
428448 sharesRestricted Stock Units
Not reportedContext evidence
SIMON, IRWIN DDirector, President and CEO
AcquisitionCommon equity
428448 sharesCommon Stock
Not reportedContext evidence
SIMON, IRWIN DDirector, President and CEO
DisposalCommon equity
227078 sharesCommon Stock
$906.0KDirectional evidence
FALTISCHEK, DENISE MChief Strategy Officer
DisposalCommon equity
49654 sharesCommon Stock
$198.1KDirectional evidence
GENDEL, MITCHELLGlobal General Counsel
DisposalCommon equity
46344 sharesCommon Stock
$184.9KDirectional evidence
MERTON, CARL AChief Financial Officer
DisposalCommon equity
30209 sharesCommon Stock
$120.5KDirectional evidence
CLANACHAN, DAVID FDirector
DisposalCommon equity
21552 sharesCommon Stock
$86.0KDirectional evidence
HERHALT, JOHANN MICHAELDirector
DisposalCommon equity
21552 sharesCommon Stock
$86.0KDirectional evidence
PERSOFSKY, RENAHDirector
DisposalCommon equity
21552 sharesCommon Stock
$86.0KDirectional evidence
HOPKINSON, DAVID G.Director
DisposalCommon equity
33556 sharesCommon Stock
$232.9KDirectional evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context